Prediction of prostate cancer: external validation of the ERSPC risk calculator in a contemporary Dutch clinical cohort

Background: The validity of prediction models needs external validation to assess their value beyond the original development setting. Objective: To report the diagnostic accuracy of the European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator (RC)3 and RC4 in a contemporary Dutch clinical cohort. Design, setting, and participants: We retrospectively identified all men who underwent prostate biopsy (PBx) in the Jeroen Bosch Hospital, The Netherlands, between 2007 and 2016. Patients were included if they met ERSPC RC requirements of age (50–80 yr), prostate-specific an... Mehr ...

Verfasser: Gayet, M.
Mannaerts, C.K.
Nieboer, D.
Beerlage, H.P.
Wijkstra, H.
Mulders, P.F.A.
Roobol, M.J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: Gayet , M , Mannaerts , C K , Nieboer , D , Beerlage , H P , Wijkstra , H , Mulders , P F A & Roobol , M J 2018 , ' Prediction of prostate cancer: external validation of the ERSPC risk calculator in a contemporary Dutch clinical cohort ' , European Urology Focus , vol. 4 , no. 2 , pp. 228-234 . https://doi.org/10.1016/j.euf.2016.07.007
Schlagwörter: Journal Article / Validation / Biopsy / Nomogram / Risk stratification / Decision aids / Prostate cancer / Prostate-Specific Antigen / Predictive Value of Tests / Humans / Middle Aged / Decision Support Techniques / Male / Prostatic Neoplasms/diagnostic imaging / Neoplasm Grading / Validation Studies as Topic / Ultrasonography / Aged / 80 and over / Prostate/anatomy & histology / Retrospective Studies / Risk Assessment/methods / Netherlands/epidemiology / /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26674378
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.tue.nl/en/publications/36327939-9260-4200-81d4-82a5aaa55795